Neuphoria Therapeutics Statistics
Total Valuation
NEUP has a market cap or net worth of $11.18 million. The enterprise value is -$2.84 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NEUP has 2.36 million shares outstanding. The number of shares has decreased by -99.94% in one year.
| Current Share Class | 2.36M |
| Shares Outstanding | 2.36M |
| Shares Change (YoY) | -99.94% |
| Shares Change (QoQ) | +18.13% |
| Owned by Insiders (%) | 7.81% |
| Owned by Institutions (%) | 48.49% |
| Float | 848,104 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| Forward PS | n/a |
| PB Ratio | 0.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.99 |
| P/OCF Ratio | 14.99 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.72 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.04% and return on invested capital (ROIC) is -12.19%.
| Return on Equity (ROE) | -64.04% |
| Return on Assets (ROA) | -7.25% |
| Return on Invested Capital (ROIC) | -12.19% |
| Return on Capital Employed (ROCE) | -13.12% |
| Revenue Per Employee | $1.96M |
| Profits Per Employee | -$1.18M |
| Employee Count | 8 |
| Asset Turnover | 0.62 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -370,972 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 10.23 |
| 200-Day Moving Average | 7.44 |
| Relative Strength Index (RSI) | 35.88 |
| Average Volume (20 Days) | 4,632,468 |
Short Selling Information
The latest short interest is 304,261, so 12.91% of the outstanding shares have been sold short.
| Short Interest | 304,261 |
| Short Previous Month | 13,622 |
| Short % of Shares Out | 12.91% |
| Short % of Float | 35.88% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, NEUP had revenue of $15.65 million and -$9.47 million in losses. Loss per share was -$5.09.
| Revenue | 15.65M |
| Gross Profit | 15.65M |
| Operating Income | -2.91M |
| Pretax Income | -9.84M |
| Net Income | -9.47M |
| EBITDA | -2.25M |
| EBIT | -2.91M |
| Loss Per Share | -$5.09 |
Full Income Statement Balance Sheet
The company has $13.65 million in cash and $85,210 in debt, giving a net cash position of $13.56 million or $5.75 per share.
| Cash & Cash Equivalents | 13.65M |
| Total Debt | 85,210 |
| Net Cash | 13.56M |
| Net Cash Per Share | $5.75 |
| Equity (Book Value) | 12.51M |
| Book Value Per Share | 5.31 |
| Working Capital | 8.83M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | 715,644 |
| Capital Expenditures | n/a |
| Free Cash Flow | 715,644 |
| FCF Per Share | $0.30 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of -18.62% and -60.52%.
| Gross Margin | 100.00% |
| Operating Margin | -18.62% |
| Pretax Margin | -62.89% |
| Profit Margin | -60.52% |
| EBITDA Margin | -14.39% |
| EBIT Margin | -18.62% |
| FCF Margin | 4.57% |
Dividends & Yields
NEUP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 99.94% |
| Shareholder Yield | 99.94% |
| Earnings Yield | -88.29% |
| FCF Yield | 6.67% |
Analyst Forecast
The average price target for NEUP is $28.00, which is 490.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.00 |
| Price Target Difference | 490.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 31.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |